Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Harvard Catalyst
When COVID Hit, Research Speed Was Key
Institutions across US have signed on to streamlined review process By BRENDA PATOINE | Harvard Catalyst May 16, 2023 Research 9 min read Image: Evgeny Lonskov/iStock/Getty Images Plus This article is part of Harvard Medical School’s continuing coverage of COVID-19. Scaling up vaccination against COVID-19 in underserved communities. Neuroimaging brain changes after SARS-CoV-2 infection. Improving mental health in LGBTQ+ communities affected by the pandemic.
Football Players Health Study Enters Next Phase
Since the beginning of the study, input from former players and their families has guided the research program. New information from the player community and their families will continue to inform the study’s direction. “The lack of independent, credible and visionary medical research for NFL players in the early 2000’s was a problem we sought to remedy in the 2011 Collective Bargaining Agreement,” said DeMaurice "De" Smith, executive director of the NFLPA.
Roadmap for a Young Investigator
What does it take to succeed in clinical and translational science? How does a young investigator navigate those early-career leaps from student/trainee to independently funded research scientist? What inspires a research focus, and how do you build a career around it? These questions were front and center for early-career scientists enrolled in Harvard Catalyst’s two-year Clinical and Translational Research Academy and KL2/Catalyst Medical Research Investigator Training programs.
When clinical trials compete: prioritising study recruitment
We must still address a fundamental set of questions involving whether prioritisation can be fair to relevant stakeholders. When evaluating this question, we will assume that, if institutions were to adopt a policy of prioritisation, they would be constrained by ethically defensible criteria—principles that are not obviously unfair and on which reasonable people might agree—when deciding which trials should be prioritised ahead of others (see Section ‘Prioritising studies’).
Patient and Physician Attitudes Toward Low-Value Diagnostic Tests
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Harvard
Contact Harvard, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack